Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Psychopharmacology (Berl). 2014 Feb 18;231(15):3055–3063. doi: 10.1007/s00213-014-3476-7

Fig. 3.

Fig. 3

Effects of D-amphetamine (5.0 μg/ 0.5 μl), microinjected bilaterally in nucleus accumbens medial shell in the presence and absence of 1-NASPM (25.0 μg), on two measures of threshold (left x-axis intercept; right M-50) in the curve-shift protocol of LHSS. n=9 per group. *p<.05, **p<.01, ***p<.005